Myriad to Conduct BRCA Testing for Abbott Drug Study

Myriad will test patients in a Phase III drug study for BRCA1 and BRCA2 mutations.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.